

NEWS

Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

Classification

Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

Categories:Company News
Author:
Origin:
Time of issue:2022-06-11
Views:0

(Summary description)Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.





Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

(Summary description)Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.

Categories:Company News
Author:
Origin:
Time of issue:2022-06-11
Views:0

Information

Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.

Voriconazole for injection is the second approved preparation by NMPA with our excipient in China. Betadex Sulfobutyl Ether Sodium, a new pharmaceutical excipient, is the key excipient of Voriconazole for injection. Zibo Qianhui initiated research and development from 2013, and the registration status in CDE turned to "A" in 2021.

Appreciating the trust and support of many customers, Betadex Sulfobutyl Ether Sodium of Qianhui is the only product that has been turned to "A" through associated review in China. Moreover, our product has also been registered in FDA and applied for CEP certificate. Product quality meets the requirements of USP and EP with manufacturing process follows GMP strictly.